AZN vs TMP · P/E 28, $288.38B cap vs P/E 7.5, rev $79.3M
AstraZeneca PLC (AZN) versus Tompkins Financial Corporation (TMP) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Tompkins Financial Corporation (TMP) is a banks - regional company listed on AMEX.
AZN does not have a complete income-statement cache yet.
Latest reported TMP revenue for 2024-12-31 was $79.3M. Net income was $71.0M. Revenue was up 5.7% from 2023-12-31 to 2024-12-31. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
Not investment advice. Open the AZN and TMP stock pages for the full models.
Not investment advice.